Cinclus Pharma Holding AB (OSTO:CINPHA) Other Long-Term Liabilities : kr-0.00 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Other Long-Term Liabilities?

Cinclus Pharma Holding AB's other long-term liabilities for the quarter that ended in Mar. 2025 was kr-0.00 Mil.

Cinclus Pharma Holding AB's quarterly other long-term liabilities increased from Sep. 2024 (kr-0.00 Mil) to Dec. 2024 (kr-0.00 Mil) but then declined from Dec. 2024 (kr-0.00 Mil) to Mar. 2025 (kr-0.00 Mil).

Cinclus Pharma Holding AB's annual other long-term liabilities declined from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) and declined from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr-0.00 Mil).

Cinclus Pharma Holding AB Other Long-Term Liabilities Historical Data

The historical data trend for Cinclus Pharma Holding AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Other Long-Term Liabilities Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial						-	-	-	-	-

Cinclus Pharma Holding AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Cinclus Pharma Holding AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines